We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:
Medicine & public health

Search Results

Showing 381-400 of 407 results

  1. CNS Adverse Events Associated with Antiepileptic Drugs

    A variety of newer antiepileptic drugs (AEDs) are now available for treating patients with epilepsy in addition to the ‘conventional’ drugs that have...

    Gina M. Kennedy, Samden D. Lhatoo in CNS Drugs
    Article 01 September 2008

  2. Use of Second-Generation Antiepileptic Drugs in the Pediatric Population

    Epilepsy is common in the pediatric population. Nine second-generation antiepileptic drugs have been approved in the US for use in epilepsy over the...

    Allison M. Chung, Lea S. Eiland in Pediatric Drugs
    Article 01 July 2008

  3. Antiepileptic Drugs in Non-Epilepsy Disorders

    Antiepileptic drugs (AEDs) are used extensively to treat multiple non-epilepsy disorders, both in neurology and psychiatry. This article provides a...

    Cecilie Johannessen Landmark in CNS Drugs
    Article 01 January 2008

  4. Brivaracetam is superior to levetiracetam in a rat model of post-hypoxic myoclonus

    In the present study, we evaluated the anti-seizure and anti-myoclonic activity of levetiracetam and brivaracetam in an established rat model of...

    K.-K. Tai, D. D. Truong in Journal of Neural Transmission
    Article 10 August 2007

  5. Acute and prophylactic treatments for migraine: present and future

    Herein I will present general principles of acute-care and preventive therapy of migraine, both in the present and the future. Details of currently...

    Alan M. Rapoport in Neurological Sciences
    Article 01 May 2008

  6. Retrospective analysis of the efficacy and tolerability of levetiracetam in patients with metastatic brain tumors

    Seizures are a common complication of metastatic brain tumors (MBT), affecting approximately 27–50% of all patients during the course of their...

    Herbert B. Newton, Jennifer Dalton, ... Dennis Pearl in Journal of Neuro-Oncology
    Article 13 April 2007

  7. Levetiracetam for the treatment of hot flashes: a phase II study

    Goals of work

    The objectives of this pilot trial were to assess the potential efficacy and safety of levetiracetam for the treatment of hot flashes, a...

    Susan Thompson, Aditya Bardia, ... Charles L. Loprinzi in Supportive Care in Cancer
    Article 28 June 2007

  8. Role of intravenous levetiracetam in status migrainosus

    Muhammad U. Farooq, Arshad Majid, ... Mounzer Y. Kassab in The Journal of Headache and Pain
    Article Open access 11 May 2007

  10. IV levetiracetam in the management of non-convulsive status epilepticus

    Introduction

    Status epilepticus (SE) is a medical emergency requiring prompt treatment to try to limit mortality and improve outcome. So far, newer...

    Muhammad U. Farooq, Bharath Naravetla, ... Mounzer Y. Kassab in Neurocritical Care
    Article 13 April 2007

  11. Tuberous sclerosis successfully treated with levetiracetam monotherapy: 18 months of follow-up

    Case

    We present the case of a boy with tuberous sclerosis who was referred for evaluation and treatment of his intractable epileptic seizures, having...

    Savvas S. Papacostas, Eleftherios S. Papathanasiou, ... Goula Stylianidou in Pharmacy World & Science
    Article 01 March 2007

  12. Levetiracetam in three cases of progressive myoclonus epilepsy

    We present three unrelated cases of genetically confirmed progressive myoclonic epilepsy of the Unverricht–Lundborg type who were treated with...

    Savvas Papacostas, Elena Kkolou, Eleftherios Papathanasiou in Pharmacy World & Science
    Article 23 January 2007

  13. Etiology and management of refractory epilepsies

    The epilepsies are an important, common and diverse group of symptom complexes characterized by recurrent spontaneous seizures. Although many...

    Sanjay Sisodiya in Nature Clinical Practice Neurology
    Article 01 June 2007

  15. Future aspects of botulinum neurotoxins

    The future of botulinum neurotoxin (BoNT) development is expected to proceed along two lines: the development of novel indications and the...

    K. R. Aoki in Journal of Neural Transmission
    Article 08 June 2007

  16. Potential of Levetiracetam in

    Levetiracetam is a newer antiepileptic agent that was first approved by the US FDA in 1999 as an adjunctive therapy for the treatment of refractory...

    Anjana Muralidharan, Zubin Bhagwagar in CNS Drugs
    Article 01 December 2006

  17. The future of acute care and prevention in headache

    Migraine is a chronic neurological disease with heterogeneous characteristics resulting in a range of symptom profiles, burden and disability. It...

    A. V. Krymchantowski, A. M. Rapoport, C. C. Jevoux in Neurological Sciences
    Article 01 May 2007

  18. Levetiracetam is neuroprotective in murine models of closed head injury and subarachnoid hemorrhage

    Objectives

    Prophylactic treatment with antiepileptic drugs is common practice following subarchnoid hemorrhage (SAH) and traumatic brain injury....

    Haichen Wang, Junling Gao, ... Daniel T. Laskowitz in Neurocritical Care
    Article 01 August 2006

  19. Pharmacokinetic Variability of Newer Antiepileptic Drugs

    A new generation of antiepileptic drugs (AEDs) has reached the market in recent years with ten new compounds: felbamate, gabapentin, lamotrigine,...

    Svein I. Johannessen, Torbjörn Tomson in Clinical Pharmacokinetics
    Article 01 November 2006

  20. Levetiracetam for cerebellar tremor in multiple sclerosis

    Purpose

    Disabling tremor is frequent in multiple sclerosis (MS) and its treatment remains challenging. We conducted an open–label trial to evaluate...

    P. Striano, A. Coppola, ... S. Striano in Journal of Neurology
    Article 12 May 2006
Did you find what you were looking for? Share feedback.